Frat Jean-Pierre, Ricard Jean-Damien, Coudroy Rémi, Robert René, Ragot Stéphanie, Thille Arnaud W
Réanimation Médicale, CHU de Poitiers, Poitiers, France.
Faculté de Médecine et de Pharmacie de Poitiers, Université de Poitiers, Poitiers, France.
BMJ Open. 2017 Dec 22;7(12):e018611. doi: 10.1136/bmjopen-2017-018611.
Endotracheal intubation in intensive care unit (ICU) is a procedure at high risk of life-threatening complications. Among them, severe oxygen desaturation, usually defined as a drop of pulse oxymetry (SpO) below 80%, is the most common. Preoxygenation enables delaying oxygen desaturation occurring during apnea induced by anaesthetic drugs. Data suggest that non-invasive ventilation (NIV) or high-flow nasal cannula (HFNC) oxygen therapy could further increase PaO before intubation procedure and prevent oxygen desaturation episodes as compared with standard oxygen. However, no recommendation favours one technique rather than the other, since they have never been compared. Hence, whether a strategy of preoxygenation with NIV or HFNC is more effective than the other in patients with acute hypoxaemic respiratory failure remains to be established.
The FLORALI-2 study is a multicentre randomised controlled trial comparing a preoxygenation strategy with either NIV or HFNC in patients with acute hypoxaemic respiratory failure needing intubation in ICU. The 320 patients will be randomised with a ratio 1:1 in two groups according to the strategy of preoxygenation. The primary outcome is the occurrence of an episode of severe oxygen desaturation defined by a drop of SpO below 80% during the intubation procedure. Secondary outcomes include feasibility of the two strategies, immediate and late complications related to intubation.
The study has been approved by the central ethics committee (Ethics Committee Ouest-III, Poitiers, France) and patients will be included after informed consent. The results will be submitted for publication in peer-reviewed journals.
NCT02668458; Pre-results.
重症监护病房(ICU)中的气管插管是一项具有危及生命并发症高风险的操作。其中,严重氧饱和度下降是最常见的,通常定义为脉搏血氧饱和度(SpO)降至80%以下。预给氧能够延迟麻醉药物诱导的呼吸暂停期间发生的氧饱和度下降。数据表明,与标准吸氧相比,无创通气(NIV)或高流量鼻导管(HFNC)氧疗可在插管操作前进一步提高动脉血氧分压(PaO)并预防氧饱和度下降事件。然而,由于从未对它们进行过比较,尚无推荐更青睐一种技术而非另一种。因此,在急性低氧性呼吸衰竭患者中,NIV或HFNC预给氧策略是否比另一种更有效仍有待确定。
FLORALI-2研究是一项多中心随机对照试验,比较在ICU中需要插管的急性低氧性呼吸衰竭患者中,NIV或HFNC预给氧策略。320例患者将根据预给氧策略按1:1比例随机分为两组。主要结局是插管过程中SpO降至80%以下定义的严重氧饱和度下降事件的发生。次要结局包括两种策略的可行性、与插管相关的即刻和延迟并发症。
该研究已获得中央伦理委员会(法国普瓦捷西部伦理委员会III)批准,患者将在获得知情同意后纳入。结果将提交至同行评审期刊发表。
NCT02668458;结果前。